Rae L. Bourne, MD

Articles by Rae L. Bourne, MD

Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis

ByRodney S. Daniel, MD,Rae L. Bourne, MD,Annie N. Simpson, MSc,Kenneth S. O'Rourke, MD,Marcy B. Bolster, MD

July 1st 2009

Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.

Latest Updated Articles

Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis
Published: July 1st 2009 | Updated:

Rae L. Bourne, MD

Articles by Rae L. Bourne, MD

Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis

Latest Updated Articles

Trending on Pharmacy Times

Breaking News: CVS Buys Rite Aid, Bartell Drugs

Young Women With Symptomatic Long COVID At Higher Risk of POTS

FDA Approves 1-Minute HIV Self-Test

Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer

Kellermensch: Living With the Emotional Weight of a Career in Health Care